Crossmark

Comprehensive analysis of the HCK gene in myeloid neoplasms: Insights into biological functions, prognosis, and response to antineoplastic agents

Crossref DOI link: https://doi.org/10.1016/j.htct.2023.11.007

Published Print: 2024-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Carvalho, Maria Fernanda Lopes http://orcid.org/0000-0002-9712-6050
de Almeida, Bruna Oliveira http://orcid.org/0000-0002-5884-1975
Bueno, Maura Lima Pereira http://orcid.org/0000-0003-2979-5145
Vicari, Hugo Passos http://orcid.org/0000-0001-6121-3315
Lima, Keli

Rego, Eduardo Magalhães

Roversi, Fernanda Marconi

Machado-Neto, João Agostinho http://orcid.org/0000-0002-2937-8109
Funding

Funding for this research was provided by:

FAPESP (2020/12842 -0, 2019/23864-7, 2021/01460-1, 2022/11038-8, 2021/11606-3, 2022/14505-6)

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
License Information

Text and Data Mining valid from 2024-07-01

Text and Data Mining valid from 2024-07-01

Version of Record valid from 2023-12-21
More Information

This article is maintained by: Elsevier

Article Title: Comprehensive analysis of the HCK gene in myeloid neoplasms: Insights into biological functions, prognosis, and response to antineoplastic agents

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2023.11.007

Content Type: article

Copyright: © 2023 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U.